Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-21

Clinical Trial Update: Rationale and Design of Diabetes Management With Curcumin and Saffron (DMCS): a Randomised, Three Blind -Blind, Placebo-controlled Study [Phase 1, Phase 2]

View source ↗

Summary

It describes the rationale and study design for a phase 1/2 randomized, triple-blind, placebo-controlled trial of curcumin and saffron for diabetes management. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)
  • Saffron (saffron extract)

Snippet

Sponsor: Fateme Moshirenia | Conditions: Women of Reproductive Age, Diabetes Mellitus | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING